A Study of CAR-T Cells in Subjects With Autoimmune Diseases

Sponsor
Chinese PLA General Hospital
Study ID
NCT07040917
Phase
EARLY_PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Autoimmune Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • CAR-T cell — DRUG
    CAR-T cell

Study Details

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.

Key Dates

First listed
Jun 27, 2025
Start date
Sep 30, 2025
Status verified
Jul 2025
Primary completion
Nov 30, 2027
Completion
Apr 30, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: CAR-T treatment

Primary Outcome Measure

Dose Limiting Toxicity [ Time Frame: 0~28 day after treatment ]

Central Contacts

Related Studies